Colorectal neoplasmas
Conditions
Interventions
0.8% l-Menthol with Carbon dioxide
0.8% l-Menthol with Air
Water with dimeticon with Carbon dioxide
Water with dimeticon with Air
Sponsors
Division of Gastroenterology and Hepatology,Fukuchiyama City Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients undergoing colonoscopy for the investigation of positive results of a fecal occult blood test screening, screening colonoscopy or surveillance colonoscopy after postendoscopic resection of colorectal neoplasmas.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had any of the following: a history of colectomy,symptoms suggesting possible colorectal stenosis or cancer, inflammatory bowel disease, familial polyposis, or known CRC, severe organ failure, noncorrectable coagulopathy, or antithrombotic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The colorectal adenoma detection rate between the L-menthol with carbon dioxide group and the placebo group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of patients with no peristalsis, the withdrawal time and the pain during colonoscopy between the L-menthol with carbon dioxide group and the placebo group. | — |
Countries
Japan
Contacts
Public ContactKen Inoue
Fukuchiyama City Hospital Gastroenterology and Hepatology
Outcome results
None listed